Rizwan Romee
Immunotherapy
Who We Fund
Since 1949, LLS has provided more than $1.5 billion to the best and the brightest blood cancer researchers and biotech companies to support their groundbreaking research. Meet grantees and the companies who’ve joined our fight to find cures and help blood cancer patients everywhere.
Justin Kline
diffuse large B-cell lymphoma, immunotherapy
Thomas LeBlanc
palliative care
Frederick Locke
lymphoma and immunotherapy
Ravindra Majeti
preleukemia, AML
Kasey Leger
pediatric blood cancers
Christopher Flowers
clinical trial access
Alex Kentsis
pediatric leukemias
Yibin Yang
Lymphoma
Shan Lin
preleukemia, leukemia
Adam Olszewski
Follicular and marginal zone lymphoma
Alex Herrera
lymphoma and immunotherapy
Jianhua Yu
myeloma immunotherapy
Tanya Siddiqi
clinical trial access
Jolanta Grembecka
leukemia therapeutics
Eugenio Morelli
Myeloma
Courtney DiNardo
clinical trials, AML
Thomas Koehnke
leukemia
Robert Soiffer
transplantation
Saar Gill
AML immunotherapy
Wendy Béguelin
follicular lymphoma
ImCheck Therapeutics
immunotherapy, AML
Steven Horwitz
T-cell lymphomas
Xu Ji
Equity in Access
Timothy Ley
AML, precision medicine
Craig Jordan
AML
Lev Kats
myeloma and epigenetics
Roberta Zappasodi
lymphoma, immunotherapy
OncoPep
vaccine, smoldering myeloma
Courtney Jones
AML metabolism
Coleman Lindsley
AML/MDS
Carl Allen
pediatric blood cancers
Tak Mak
Immunotherapy
Clara Reglero
pediatric ALL
Megan McNerney
AML/MDS
Jaroslaw Maciejewski
bone marrow failure
Reshmi Parameswaran
immunotherapy for hairy cell leukemia
Daniel Pollyea
AML
George Vassiliou
pre-leukemia
Daniel Lucas
bone marrow and leukemia biology
John Pimanda
AML, MDS
Michael Savona
MDS and leukemia
Kevin Shannon
pediatric AML
Areej El-Jawahri
transplant survivorship
Therese Vu
T-All and MLL
Alieen Rowan
Adult T cell leukemia/lymphoma
Keisuke Ito
blood cancer stem cells
Stephen Nimer
myeloid cancer biology
Affimed
immunotherapy, PTCL
Kirsten Williams
leukemia, immunotherapy
Philippe Armand
lymphoma and immunotherapy
Robert Signer
cancer stem cell biology
David Fruman
novel combinations
Ravi Bhatia
transplantation
Jonathan Licht
DNA biology, myeloma
Omar Abdel-Wahab
Hairy cell leukemia
Caribou Biosciences
immunotherapy, allo-CAR, NHL, MM, AML
Jonas Jutzi
myeloproliferative neoplasms
Jennifer Woyach
CLL trials
Kura Oncology
MLL leukemia, AML
Stacie Dusetzina
Equity in Access
Dane Vassiliadis
blood cancer biology
Catherine Smith
leukemia
Caron Jacobson
lymphoma and immunotherapy
Ari Melnick
epigenetics and lymphoma
Nicolas Nassar
pediatric leukemia
Sisi Chen
leukemia
Stephen Oh
myeloproliferative neoplasms
Immunitas Therapeutics
immunotherapy, DLBCL, Hodgkin's
Michael Keller
COVID-19, immunotherapy
Joachim Yahalom
Lymphoma
Sami Malek
blood cancer biology
Zhijian Qian
blood cancer stem cells
Julia Maxson
AML
Helen Heslop
Immunotherapy
Susan Schwab
cancer immunology
Christian Steidl
B-cell lymphomas
Scott Armstrong
pediatric blood cancers
Juliette Bouyssou
leukemias and gender
Tomasz Skorski
myeloproliferative neoplasms, AML
Ryvu Therapeutics
AML, MDS
Jane Oliaro
Myeloma & Lymphoma Immunotherapy
Mitchell Geer
leukemia biology
Samuel Taylor
leukemia biology
Margaret Shipp
lymphoma biology
Larry Kwak
Mantle cell lymphoma, immunotherapy
Charles Mullighan
pediatric ALL
Immune-Onc Therapeutics
immunotherapy, AML, CMML
Madhav Dhodapkar
multiple myeloma immunotherapy
David Ritchie
Hairy Cell Leukemia
Christopher Reilly
leukemia
Dren Bio
immunotherapy, LGLL
Rajni Kumari
AML
Soheil Meshinchi
pediatric AML
BioTheryX
protein degraders, AML
Michael Green
lymphoma biology
Grant Challen
preleukemia, leukemia
Kerry Rogers
CLL
Matteo Bellone
Smoldering multiple myeloma
Simona Colla
Myeloma biology
Yan Liu
MDS
Daniel Herranz
T-ALL
Suzanne Lentzsch
Myeloma
Amer Zeidan
MDS and AML
Thomas Kipps
Hairy Cell Leukemia
Andrew Lane
BPDCN
Michael Kharas
leukemia
Frederike Kramer
MPNs
Marco Ruella
Immunotherapy for T-cell lymphoma
Neha Mehta-Shah
T-cell lymphoma
Faron Pharmaceuticals
immunotherapy, AML, CMML
Suman Paul
T cell cancers and immunotherapy
Nathan Ungerleider
lymphoma biology
Kimberly Stegmaier
childhood blood cancers
Gareth Morgan
smoldering myeloma, MGUS
Catriona Jamieson
cancer stem cell biology
Sylvain Simon
Immunotherapy, CAR-T safety
Piers Patten
COVID-19
Michael Rout
follicular lymphoma, CAR T
Christina Glytsou
leukemia therapeutics
Sattva Neelapu
DLBCL, CAR T
Eirini Papapetrou
blood cancer stem cells
F. Lennie Wong
Equity in Access
Nitin Jain
CLL
Johanna Melo-Cardenas
Primary Myelofibrosis
Constellation Pharmaceuticals
myeloproliferative neoplasms
Ann-Kathrin Eisfeld
Racial diversity in AML
Christopher Porter
Leukemia, lymphoma
Riccardo Dalla-Favera
diffuse large B-cell lymphoma
Arash Alizadeh
blood cancer biology and diagnosis
Bruno Paiva
smoldering myeloma
Jaehyuk Choi
T-cell lymphoma
Richard Lock
T-ALL
Brian Walker
smoldering myeloma, MGUS
Alfred Garfall
myeloma immunotherapy
Robert Orlowski
(Smoldering) Multiple Myeloma
Shannon McKinney-Freeman
transplant biology
Dan Vogl
myeloma, microenvironment
Hong Wen
AML
Abintus Bio
immunotherapy, in vivo CAR
Kymera Therapeutics
protein degraders, DLBCL, TCL, LGLL
Jun Qi
Myeloma
Logan Spector
childhood leukemia epidimiology
Ronald Levy
immunotherapies, COVID-19
Daniel Thomas
Myelofibrosis
Brian Dalton
DNA mutations and myeloid cancers
Gongwei Wu
lymphoma biology
Rong Lu
preleukemia, leukemia
Caner Saygin
T-ALL
Venkata Lokesh Battula
immunotherapy and AML
Mala Shanmugam
myeloma
Christiane Querfeld
T-cell lymphoma
Kathleen Sakamoto
pediatric AML
Qingyu Luo
BPDCN
Liran Shlush
pre-leukemia
Dan Landau
cancer evolution biology
Carl June
CAR T immunotherapy
Terry Fry
CAR T and pediatric AML
BioInvent International
immunotherapy, indolent NHL, CTCL
Catherine Bollard
pediatric blood cancers and immunotherapy
Jian Xu
leukemia and MPN biology
Koichi Takahashi
AML/MDS
Jason Butler
aging and leukemia
Kirk Schultz
pediatric transplantation
Amit Verma
AML/MDS
Thorsten Zenz
Hairy cell leukemia
Ryan Wilcox
T-cell lymphoma
Daisuke Nakada
preleukemia, leukemia
Forty Seven
immunotherapy, MDS, DLBCL
Lakshmi Nayak
brain tumors in lymphoma
Clayton Smith
clinical trial access
John Leonard
lymphoma research
Katherine Borden
AML
Enrico Tiacci
Hairy cell leukemia
Mark Hamilton
DLBCL and CAR-T
Peng Ji
myeloproliferative neoplasms
Noemí Puig Morón
Myeloma
Siddhartha Jaiswal
preleukemia
Jeffrey Magee
pediatric AML
Marc Seifert
Hairy cell leukemia
Srividya Swaminathan
pediatric, immunotherapy
Elvin Wagenblast
Down syndrome-associated leukemia
Jeremy Baeten
AML
Maria "Ken" Figueroa
aging and leukemia
Carisma Therapeutics
immunotherapy, CAR-macrophage
Ricky Johnstone
lymphoma and myeloma
Loren Walensky
pediatric leukemia
Aditi Shastri
AML, MDS
Sameer Parikh
COVID-19
Nirav Shah
CAR-T for lymphoma
Alec Zhang
myeloma, immunotherapy
Paolo Strati
Non-Hodgkin Lymphoma
Lucy Godley
preleukemia
Lei Ding
myeloproliferative neoplasms, myelofibrosis
Jennifer Trowbridge
aging and leukemia
Alison Moskowitz
lymphoma therapeutics
Randall Davis
CLL
Markus Muschen
leukemia and lymphoma biology
Sigurður Kristinsson
Smoldering myeloma
Selina Chen-Kiang
Mantle cell lymphoma
Grzegorz Nowakowski
Clinical trial access
Luca Busino
DLBCL
Ryotaro Nakamura
ALL, CAR T
Matthew Davids
lymphoma therapeutics
Alexey Danilov
lymphoma
Baochun Zhang
immunotherapy
Sean Post
diffuse large B-cell lymphoma
Tycel Phillips
Mantle Cell Lymphoma
Ivan Maillard
transplant biology
Sarah Tasian
pediatric leukemias
G. Greg Wang
DNA biology
Robert Kridel
follicular lymphoma
Christopher Booth
BPDCN
Daniel Starczynowski
MDS and AML
Robert Bradley
MDS
Sutro Biopharma
immunotherapy, NHL, myeloma
Gianpietro Dotti
CAR T and AML
Amin Sobh
Myeloma biology
Peter Klein
MDS
Hao Jiang
leukemia biology
Timothy Graubert
AML and MDS biology
Alexandra Stevens
childhood AML